Editor-in-Chief:

John K. Buolamwini
Department of Pharmaceutical Sciences
College of Pharmacy
University of Tennessee Health Science Center
847 Monroe Avenue, Suite 327
Memphis, TN 38163,
USA

Associate Editors:

Alex A. Adjei
Roswell Park Cancer Institute
Buffalo, NY,
USA


Francis Ali-Osman
Comprehensive Cancer Center
Duke University Medical Center
Durham, NC,
USA


Nouri Neamati
University of Southern California
Los Angeles, CA,
USA


Herbert E. Nieburgs
Department of Pathology
University of Massachusetts
MA,
USA


Silvio Parodi
National Institute for Research on Cancer
University of Genoa
Genoa,
Italy


Takashi Sugimura
National Cancer Center Research Institute
Tokyo,
Japan


Paul Workman
Cancer Research UK Centre for Cancer Therapeutics
The Institute for Cancer Research
Surrey, England
UK

Editorial Advisory Board:

Sarki A. Abdulkadir (Vanderbilt University Medical Center, Nashville, TN, USA)
Sudhir Agrawal (Idera Pharmaceuticals, Inc., Cambridge, MA, USA)
Joseph J. Barchi Jr. (National Cancer Institute, Frederick, MD, USA)
Terrence R. Burke Jr. (National Cancer Institute, Bethesda, MD, USA)
Michele Caraglia (Second University of Naples, Naples, Italy)
Michael P. Carty (National University of Ireland, Galway City, Ireland)
Patrick J. Casey (Duke-NUS Medical School Singapore, Singapore, Singapore)
Carol E. Cass (University of Alberta, Edmonton, Alberta, Canada)
Zeger Debyser (Rega Institute for Medical Research, Leuven, Belgium)
Silvio De Flora (University of Genoa, Genoa, Italy)
William A. Denny (The University of Auckland, Auckland, New Zealand)
Assam El-Osta (Baker Medical Research Institute, Victoria, Australia)
Manel Esteller (Spanish National Cancer Centre (CNIO), Madrid, Spain)
Lynn Ferguson (University of Auckland, Auckland, New Zealand)
Michelle Haber (University of New South Wales, Sydney, Australia)
Ingunn Holen (University of Sheffield, Sheffield, England)
Chuanshu Huang (New York University School of Medicine, NY, USA)
Nam-ho Huh (Okayama University Graduate School of Medicine, Okayama, Japan)
Johji Inazawa (Tokyo Medical and Dental University, Tokyo, Japan)
Hideki Kasuya (Nagoya University School of Medicine, Nagoya Aichi, Japan)
Evan T. Keller (University of Michigan, Ann Arbor, MI, USA)
Robert S. Kerbel (Sunnybrook & Women's College Health Sciences Centre, Toronto, Canada)
Marene Landström (Ludwig Institute for Cancer Research, Uppsala, Sweden)
Edision T. Liu (Genome Institute of Singapore, Singapore)
Ya-Qiu Long (Shanghai Institute of Materia Medica, Shanghai, China)
Sridhar Mani (Albert Comprehensive Cancer Center, Bronx, NY, USA)
David J. McConkey (MD Anderson Cancer Center, Houston, TX, USA)
Masato Mutoh (Toray Industries, Inc., Kamakura, Kanagawa, Japan)
Alessio Nencioni (University of Genoa, Genoa, Italy)
Kyriacos C. Nicolaou (Scripps Research Institute, San Diego, CA, USA)
Yuan-Ping Pang (Mayo Clinic Cancer Center, Rochester, MN, USA)
Franco Patrone (University of Genova, Genova, Italy)
Yves Pommier (National Cancer Institute, Bethesda, MD, USA)
Garth Powis (Arizona Cancer Center, Tucson, AZ, USA)
Balazs Sarkadi (National Medical Center, Budapest, Hungary)
Stefania Scala (National Cancer Institute "G. Pascale", Naples, Italy)
M.S. Sheikh (SUNY Upstate Medical University, Syracuse, NY, USA)
Beverly A. Teicher (Genzyme Corporation, Framingham, MA, USA)
George S.W. Tsao (University of Hong Kong, Hong Kong)
Kristiina Vuori (The Burnham Institute, La Jolla, CA, USA)
John N. Weinstein (National Cancer Institute, Bethesda, MD, USA)
Daniel Zaharevitz (National Cancer Institute, Rockville, MD, USA)
Ruiwen Zhang (Texas Tech University Health Sciences Center, Amarillo, TX, USA)